KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Return on Equity (2016 - 2025)

Historic Return on Equity for Edwards Lifesciences (EW) over the last 16 years, with Q3 2025 value amounting to 0.0%.

  • Edwards Lifesciences' Return on Equity fell 3200.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year decrease of 3200.0%. This contributed to the annual value of 0.33% for FY2024, which is 3000.0% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Return on Equity of 0.0% as of Q3 2025, which was down 3200.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Return on Equity peaked at 0.32% during Q3 2024, and registered a low of 0.0% during Q3 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.24% (2022), whereas its average is 0.19%.
  • Per our database at Business Quant, Edwards Lifesciences' Return on Equity soared by 2700bps in 2024 and then plummeted by -3200bps in 2025.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Return on Equity stood at 0.26% in 2021, then decreased by -17bps to 0.22% in 2022, then plummeted by -88bps to 0.03% in 2023, then skyrocketed by 957bps to 0.28% in 2024, then tumbled by -99bps to 0.0% in 2025.
  • Its Return on Equity was 0.0% in Q3 2025, compared to 0.26% in Q2 2025 and 0.27% in Q1 2025.